Impaired activation of murine platelets lacking Gαi2

Journal of Clinical Investigation

Volumn 108, Issue 3, 2001, Pages 477-483

  Jantzen, Hans Michael ^a   Milstone, David S ^b   Gousset, Laurent ^a   Conley, Pamela B ^a   Mortensen, Richard M ^c  

^a MILLENNIUM PHARMACEUTICALS INC   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENYLATE CYCLASE; FIBRINOGEN RECEPTOR; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; PURINE P2Y RECEPTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HEMOSTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOGENESIS;

EID: 0034897374     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI12818     Document Type: Article

References (35)

1. Integrin signaling: The platelet paradigm
2. Identification of the pertussis toxin-sensitive G proteins in platelets, megakaryocytes, and human erythroleukemia cells
3. i2 proteins
4. Signaling through G proteins in platelets: Ro the integrins and beyond
5. The role of heterotrimeric G proteins in platelet activation
6. q-deficient mice
7. z, results in abnormal platelet activation and altered responses to psychoactive drugs
8. Molecular basis for ADP-induced platelet activation. II The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets
9. Role of P2Y1 purinoceptor in ADP-induced platelet activation
10. 1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrel
11. ADP-receptors
12. Ligand specificity and ticlopidine effects distinguish three human platelet ADP receptors
13. Evidence for two distinct G-protein -coupled ADP receptors mediating platelet activation
14. Identification of the platelet ADP receptor targeted by antithrombotic drugs
15. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation
16. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP
17. cAMP is not an important messenger for ADP-induced platelet aggregation
18. Role of intracellular signaling events in ADP-induced platelet aggregation
19. i2α-/- mice
20. i3 is required for muscarinic inhibition of contractility and calcium currents in adult cardiomyocytes
21. ADP receptors and clinical bleeding disorders
22. Integrin cytoplasmic tyrosine motif is required for outside-in αIIbβ3 signalling and platelet function
23. ADP induces partial platelet aggregation without shape change and potentiates collagen-induced aggregation in the absence of Gαq
24. Platelet shape change is mediated by both calcium-dependent and -independent signaling pathways. Role of p160 Rho-associated coiled-coil-containing protein kinase in platelet shape change
25. β3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival
26. 2A receptors
27. A key role of adenosine diphosphate in the irreversible platelet aggregation induced by the PAR1-activating peptide through the late activation of phosphoinositide 3-kinase
28. 1
29. 2τ receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity
30. Structure-function analysis of protease-activated receptor 4 tethered ligand peptides. Determinants of specificity and utility in assays of receptor function
31. Thrombin signaling and protease-activated receptors
32. 2+-mediated activation of Rap1 in human platelets
33. Epac is a Rap 1 guanine-nucleotide-exchange factor directly activated by cyclic AMP
34. i
35. G protein beta gamma subunits